Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes

Human Gene Therapy

Volumn 10, Issue 14, 1999, Pages 2315-2323

  Sisson, Thomas H ^a   Hattori, Noboru ^a   Xu, Yin ^a   Simon, Richard H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COMPLEMENTARY DNA; HYDROXYPROLINE; UROKINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GENE THERAPY; GENE TRANSFER; LUNG DISEASE; LUNG FIBROSIS; MOUSE; NONHUMAN;

ADENOVIRIDAE; ANIMALS; BLEOMYCIN; COLLAGEN; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, TRANSGENIC; PULMONARY FIBROSIS; URINARY PLASMINOGEN ACTIVATOR;

ADENOVIRIDAE; ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0033588866     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016960     Document Type: Article

References (34)

1. BACHOFEN, A., and WEISEL, E.R. (1977). Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116, 589-615.
2. BASSET, F., FERRANS, V.J., SOLER, P., TAKEMURA, T., FUKUDA, Y., and CRYSTAL, R.G. (1986). Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122, 443-461.
3. BERTOZZI, P., ASTEDT, B., ZENZIUS, L., LYNCH, K., LEMAIRE, F., ZAPOL, W., and CHAPMAN, H.J. (1990). Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322, 890-897.
4. CHAPMAN, H.A., ALLEN, C.L., and STONE, O.L. (1986). Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133, 437-443.
5. CHEUNG, T., LUI, A.Y.Y., and LAU, H.K.F. (1993). Characterization of radioimmunoassays for high-and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma. J. Lab. Clin. Med. 121, 461-471.
6. EECKHOUT, Y., and VAES, G. (1977). Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J. 166, 21-31.
7. EITZMAN, D.T., McCOY, R.D., ZHENG, X., FAY, W.P., SHEN, T., GINSBURG, D., and SIMON, R.H. (1996). Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232-7.
8. ELLIS, V., BEHRENDT, N., and DANO, K. (1991). Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266, 12752-12758.
9. ENGELHARDT, J.F., SIMON, R.H., YANG, Y., ZEPEDA, M., WEBER, P.S., DORANZ, B., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study. Hum. Gene Ther. 4, 759-769.
10. FUKUDA, Y., ISHIZAKI, M., MASUDA, Y., KIMURA, G., KAWANAMI, O., and MASUGI, Y. (1987). The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126, 171-182.
11. GROSS, T.J., SIMON, R.H., and SITRIN, R.G. (1990). Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 3, 449-456.
12. GYETKO, M.R., CHEN, G.H., McDONALD, R.A., GOODMAN, R., HUFFNAGLE, G.B., WILKINSON, C.C., FULLER, J.A., and TOEWS, G.B. (1996). Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest. 97, 1818-1826.
13. HART, D.A., WHIDDEN, P., GREEN, F., HENKIN, J., and WOODS, D.E. (1994). Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin. Invest. Med. 17, 69-76.
14. HATTORI, N., SISSON, T.H., XU, Y., and SIMON, R.H. (1999). Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo. Hum. Gene Ther. 10, 215-222.
15. IDELL, S., JAMES, K.K., GILLIES, C., and FAIR, D.S. (1989a). Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 137, 387-389.
16. IDELL, S., JAMES, K.K., LEVIN, E.G., SCHWARTZ, B.S., MANCHANDA, N., MAUNDER, R.J., MARTIN, T.R., McLARTY, J., and FAIR, D.S. (1989b). Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84, 695-705.
17. IDELL, S., JAMES, K.K., and COALSON, J.J. (1992). Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: Trends in two forms of lung injury. Crit. Care Med. 20, 1431-1440.
18. IKEDA, T., HIROSE, N., KOTO, H., HIRANO, H., and SHIGEMATSU, N. (1989). Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis. Nippon Kyobu Shikkan Gakkai Zasshi 27, 448-451.
19. KOTANI, I., SATO, A., HAYAKAWA, H., URANO, T., TAKADA, Y., and TAKADA, A. (1995). Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77, 493-504.
20. LIJNEN, H.R., VAN HOEF, B., and COLLEN, D. (1996). Characterization of the murine plasminogen/urokinase-type plasminogen-activator system. Eur. J. Biochem. 241, 840-848.
21. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD, P.L., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
22. McCOY, R.D., DAVIDSON, B.L., ROESSLER, B.J., HUFFNAGLE, G.B., and SIMON, R.H. (1995). Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: Effects on vector-induced inflammation. Gene Ther. 2, 437-442.
23. OLMAN, M.A., MACKMAN, N., GLADSON, C.L., MOASER, K.M., and LOSKUTOFF, D.J. (1995). Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96, 1621-1630.
24. 2 metabolite producing enzyme system. Chest 83(Suppl. 5), 44S-45S.
25. POWELL-JONES, C.H. (1988). Rapid SDS-PAGE zymography of plasminogen activators. Thromb. Res. 49, 299-302.
26. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD, P.L., PERRICAUDET, J., JALLAT. S., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
27. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, J., GUGGINO, W.B., LECOCQ, J.P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
28. SCHRIER, D.J., and PHAN, S.H. (1984). Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells. Am. J. Pathol. 116, 270-278.
29. SCHRIER, D.J., KUNKEL, R.G., and PHAN, S.H. (1983). The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127, 63-66.
30. SIMMONS, W.L., RIVERA, K.E., CURIEL, D.T., WILLIAMS, W.F., and OLMAN, M.A. (1998). Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs. Am. J. Respir. Cell Mol. Biol. 18, 307-314.
31. SUFFREDINI, A.F., HARPEL, P.C., and PARRILLO, J.E. (1989). Promotion and subsequent inhibition of plasminogen activation after administration intravenous endotoxin to normal subjects. N. Engl. J. Med. 320, 1165-1172.
32. VISCARDI, R.M., BRODERICK, K., SUN, C.C., YALE, L.A., HESSAMFAR, A., TACIAK, V., BURKE, K.C., KOENIG, K.B., and IDELL, S. (1992). Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am. Rev. Respir. Dis. 146, 492-499.
33. WILSON, J.M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187.
34. WOESSNER, J.J. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.